性别、年龄和阳性阈值对粪便免疫化学检测准确性影响的系统评价与荟萃分析
结果显示阈值≤10 μg/g时CRC灵敏度80%、进展期腺瘤31%、特异度91%,阈值>10且≤20 μg/g时分别为69%、21%、94%。按性别和年龄分层的研究较少,阈值需个体化。
要点
- FIT阳性阈值降低可提高CRC和进展期腺瘤检出灵敏度,但特异度下降。
- 阈值≤10 μg/g时CRC灵敏度80%,进展期腺瘤31%,特异度91%。
- 性别和年龄亚组研究有限,暂不能精确设定各亚组阈值。
核心结论
- FIT检测CRC和进展期腺瘤的灵敏度与特异度随阳性阈值变化,阈值越低灵敏度越高但特异度越低。
- 对于结肠镜随访资源充足的中心,可能可以降低阳性阈值。
- 需要更多研究来精确确定各性别和年龄亚组的FIT阈值。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE和EMBASE,纳入无症状成人筛查中FIT检测CRC的研究。
- 按阳性阈值≤10 μg/g、10至≤20 μg/g、20至≤30 μg/g和>30 μg/g分析灵敏度和特异度。
主要发现
- CRC灵敏度从阈值>10且≤20 μg/g的69%(95%CI 63%-75%)升至阈值≤10 μg/g的80%(95%CI 76%-83%)。
- 进展期腺瘤灵敏度从阈值>10且≤20 μg/g的21%(95%CI 18%-25%)升至阈值≤10 μg/g的31%(95%CI 27%-35%)。
- 特异度从阈值>10且≤20 μg/g的94%(95%CI 93%-96%)降至阈值≤10 μg/g的91%(95%CI 89%-93%)。
- 3项按性别分层研究中,CRC灵敏度男性77%(95%CI 75%-79%),女性81%(95%CI 60%-100%)(P=.68)。
- 3项按年龄分层研究中,CRC灵敏度50-59岁85%(95%CI 71%-99%),60-69岁73%(95%CI 71%-75%)(P=.10)。
关键数值与推荐
- 阈值≤10 μg/g:CRC灵敏度80%(95%CI 76%-83%),进展期腺瘤灵敏度31%(95%CI 27%-35%),特异度91%(95%CI 89%-93%)。
- 阈值>10且≤20 μg/g:CRC灵敏度69%(95%CI 63%-75%),进展期腺瘤灵敏度21%(95%CI 18%-25%),特异度94%(95%CI 93%-96%)。
临床怎么用
- 筛查机构可根据结肠镜随访资源选择FIT阳性阈值,资源充足时可考虑降低阈值以提高灵敏度。
- 性别和年龄对FIT准确性的影响尚不明确,暂不能据此调整阈值。
局限性
- 按性别和年龄分层的研究数量较少(各3项),亚组结论不确定性大。
- 不同研究间阈值分组和参考标准可能存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Quantitative fecal immunochemical tests (FITs) for hemoglobin are commonly used for colorectal cancer (CRC) screening. We aimed to quantify the change in CRC and advanced adenoma detection and number of positive test results at different positivity thresholds and by sex and age. METHODS: We searched MEDLINE and EMBASE, selecting articles of FIT for CRC detection in asymptomatic adults undergoing screening. We calculated sensitivity and specificity, as well as detected number of cancers, advanced adenomas, and positive test results at positivity thresholds ≤10 μg hemoglobin/g feces, 10 to ≤20 μg/g, 20 to ≤30 μg/g, and >30 μg/g. We also analyzed results from stratified by patient sex, age, and reference standard. RESULTS: Our meta-analysis comprised 46 studies with 2.4 million participants and 6478 detected cancers. Sensitivity for detection of CRC increased from 69% (95% confidence interval [CI], 63%-75%) at thresholds >10 μg/g and ≤20 μg/g to 80% (95% CI, 76%-83%) at thresholds ≤10 μg/g. At these threshold values, sensitivity for detection of advanced adenomas increased from 21% (95% CI, 18%-25%) to 31% (95% CI, 27%-35%), whereas specificity decreased from 94% (95% CI, 93%-96%) to 91% (95% CI, 89%-93%). In 3 studies stratified by sex, sensitivity of CRC detection was 77% in men (95% CI, 75%-79%) and 81% in women (95% CI, 60%-100%) (P = .68). In 3 studies stratified by age groups, sensitivity of CRC detection was 85% for ages 50-59 years (95% CI, 71%-99%) and 73% for ages 60-69 years (95% CI, 71%-75%) (P = .10). All studies with colonoscopy follow-up had similar sensitivity levels for detection of CRC to studies that analyzed 2-year registry follow-up data (74%; 95% CI, 68%-78% vs 75%; 95% CI, 73%-77%). CONCLUSIONS: In a meta-analysis of studies that analyzed detection of CRC and advanced adenomas at different FIT positivity thresholds, we found the sensitivity and specificity of detection to vary with positive cutoff value. It might be possible to decrease positive threshold values for centers with sufficient follow-up colonoscopy resources. More research is needed to precisely establish FIT thresholds for each sex and age subgroup. PROTOCOL: PROSPERO CRD42017068760.
引用
- Selby K, Levine EH, Doan C, et al. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis. Gastroenterology. 2019. PMID: 31472152. doi:10.1053/j.gastro.2019.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。